Victrex plc (LON:VCT – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as GBX 828 and last traded at GBX 816, with a volume of 207575 shares traded. The stock had previously closed at GBX 819.
Wall Street Analysts Forecast Growth
VCT has been the topic of a number of recent research reports. Jefferies Financial Group reiterated a “hold” rating and set a GBX 595 target price on shares of Victrex in a research note on Tuesday, July 7th. Berenberg Bank boosted their price target on Victrex from GBX 600 to GBX 680 and gave the company a “hold” rating in a research note on Wednesday, July 8th. UBS Group reaffirmed a “sell” rating and issued a GBX 575 price objective on shares of Victrex in a report on Monday, May 11th. Finally, Canaccord Genuity Group cut Victrex to a “buy” rating and set a GBX 725 price objective on the stock. in a research report on Friday, May 15th. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of GBX 663.33.
Read Our Latest Stock Report on Victrex
Victrex Stock Down 0.4%
Victrex (LON:VCT – Get Free Report) last released its quarterly earnings results on Monday, May 11th. The company reported GBX 17.20 earnings per share for the quarter. The company had revenue of £147.10 million during the quarter. Victrex had a negative net margin of 6.70% and a negative return on equity of 4.95%. As a group, research analysts forecast that Victrex plc will post 73.1078905 earnings per share for the current fiscal year.
Victrex Company Profile
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Recommended Stories
- Five stocks we like better than Victrex
- Atlassian Just Pulled Off the Software Comeback Wall Street Wanted
- AST SpaceMobile Earnings Just Reminded Investors How Risky Space Can Be
- NVIDIA’s Rally Sets Up a Bigger Test Ahead of Earnings
- Apple’s Next iPhone Could Test How Much Pricing Power Is Left
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.
